MyFinsight
Home
Blog
About
Investment securities
$194,489K
(-1.06%↓ Y/Y)
Cash and cash
equivalents
$12,907K
(-34.49%↓ Y/Y)
Prepaid expenses and
other current assets
$4,617K
(31.24%↑ Y/Y)
Property and equipment
$3,266K
(1.65%↑ Y/Y)
Total current assets
$212,013K
(-3.54%↓ Y/Y)
Right-of-use asset
$2,422K
(32.06%↑ Y/Y)
Property and equipment,
net
$694K
(-44.83%↓ Y/Y)
Less accumulated
depreciation
$2,572K
(31.56%↑ Y/Y)
Total assets
$215,129K
(-3.48%↓ Y/Y)
Total liabilities and
stockholders' equity
$215,129K
(-3.48%↓ Y/Y)
Total stockholders'
equity
$201,858K
(-5.25%↓ Y/Y)
Total liabilities
$13,271K
(34.74%↑ Y/Y)
Accumulated deficit
-$334,807K
(-26.82%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$771K
(-352.79%↓ Y/Y)
Additional paid-in capital
$537,430K
(12.73%↑ Y/Y)
Total current
liabilities
$11,240K
(28.50%↑ Y/Y)
Operating lease liability
$2,031K
(84.30%↑ Y/Y)
Common stock, 0.0001
par value...
$6K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$8,099K
(4.72%↑ Y/Y)
Accounts payable
$3,141K
(210.07%↑ Y/Y)
Back
Back
Balance Sheet
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN)
source: myfinsight.com